Stanford researchers in the Goldberg lab have developed a novel method for targeted gene therapy delivery to retinal astrocytes for the treatment of glaucoma and other optic neuropathies.
Stanford researchers in the Goldberg lab have discovered two novel gene therapy targets for the treatment of glaucoma and other optic neuropathies. Glaucoma is the leading cause of irreversible blindness world-wide, affecting millions of adults in the United States alone.
To date, there are no treatments to restore neurologic function for the 7 million US patients suffering from chronic ischemic stroke. NR1 therapy provides a novel treatment for this unmet need.
Scientists in the Zhenan Bao Research Group at Stanford developed a process for direct photo-patterning of electronic polymers that improves device density of elastic circuits over 100x.
Researchers at Stanford University have identified a small molecule tryptase inhibitor for treatment of severe allergies. Mast cells are a part of the innate and adaptive immune response. Mast Cell activation results in release of granules containing tryptases.
Stanford engineers have developed an optical modulator to enable low-cost and high spatial-resolution time-of-flight imaging and LiDAR with low-cost standard image sensors.
Dr. Curt Scharfe and colleagues have developed RUSPseq, a method for next generation molecular testing originally conceived to diagnose metabolic disorders in newborns.
Researchers at Stanford University have developed a rapid and sensitive bioluminescent assay for screening bacterial infections using enzyme-produced photo emission for detection of beta lactamase activity.
Stanford researchers have developed a multi-omics method for predicting the strength and durability of immune responses to vaccines shortly after vaccination. The COVID-19 pandemic was a grave demonstration of the threat pandemics pose to global public health.
During post-silicon validation and debug, manufactured integrated circuits (ICs) are tested in actual system environments to detect and fix design flaws (bugs). Existing techniques are costly due to ad hoc, manual methods.
Stanford researchers in The Tang Group have developed a reproducible, high throughput device that dices tissue into uniformly sized sub-millimeter sample fragments.
Stanford engineers have prototyped and tested a flexible, soft growing robot that can deploy sensor networks for investigation in constrained spaces (see video below). Existing sensors for growing robots have focused on moving with the tip of the robot.